Bridgehead has been acquired by GfK
- Service: M&A
- Sector: Healthcare
- Sub Sector: Pharma Commercialisation Services
- Engagement Type: Sell Side
With the increasing legislation and pressure on pricing in the global healthcare industry Market Access consulting has truly come to the fore. So much so that in recent years it has spawned an industry of specialist firms who support pharma and med-tech businesses seeking market access solutions. Bridgehead is one such firm and it has worked hard to build a market-leading offer that includes research and consulting capabilities as well as unique access to key industry stakeholders globally.
The shareholders believed that the growth in the sector was only going to accelerate and this strong growth could be leveraged further by partnering with an international network that would provide access to additional markets and major international healthcare brands.
At the same time the optimum partner would offer a strong cultural and strategic fit and provide opportunities for the ongoing development of the Bridgehead International business and its senior management team.
Results identified 27 potential partners who could meet the shareholders’ objectives of whom 7 made offers. GfK, the leading global research firm ultimately offered the best strategic opportunity to develop the business further.
As part of Gfk, Bridgehead becomes the core of a market access offer within a larger research and consulting business with global reach.
The team provided fantastic support throughout the sale process and enabled the company to achieve a much better outcome than was originally thought possible…
Dr Fiona Paton
Co-Founder & Director, Bridgehead